Posted by Richard Willett - Memes and headline comments by David Icke Posted on 16 December 2023

As Side-Effects of ‘Covid’ Fake Vaccines Piled Up, the MHRA Expanded its Advice Lists But Took No Action

wrote here about the fact that MHRA’s definition of ‘safe’ is relative – “the benefits outweigh the risks” – whereas all other safety sectors define ‘safe’ in absolute terms – one in a million probability of death, one in a thousand probability of serious injury, etc. Other sectors define these up front and then investigate all safety incidents and take appropriate action to limit, modify or suspend the product if those absolute safety risks are breached in practice.

MHRA would doubtless argue that manufacturers have to put absolute safety risks in the Patient Information Leaflets which you find in the box. That’s true, there are probabilities (‘common’, ‘rare’, ‘very rare’, or one in 100, one in 1,000 etc.) However, there’s a big problem: those aren’t thresholds which, if breached, trigger MHRA to take action to limit, modify or withdraw the medicine. Instead, MHRA just seems to list all the emerging side-effects in the Patient Information Leaflets and carries on.

To illustrate this, I’ve had a poke around the evolving versions of the Patient Information Leaflets for the Covid vaccines since rollout started. It’s terrifying. I’ll show you them in a moment, but what it’s been doing as Yellow Card reports rapidly accumulated is to:

1. Move already known adverse events between frequency categories if they turn out to be more common than they thought based on the (much shorter than normal) clinical trials.

2. Add new adverse events which only emerged during rollout (i.e., they weren’t identified in the clinical trials).

Worse still, months after rollout started, MHRA:

3. Added a new category (‘1 in 10,000’).

4. Added some words on the risk of death (which wasn’t previously mentioned at all).

You can see this in all its glory by using the Wayback Machine for Pfizer/BioNTech, AstraZeneca and Moderna. Go to the version of that webpage archived on the various dates shown and then find the corresponding Patient Information Leaflet.

Space doesn’t permit showing you them all, but just spot the differences between the first AstraZeneca PIL (December 30th 2020) and the most recent (November 2023).

Read More: As Side-Effects of Covid Vaccines Piled Up, the MHRA Expanded its Advice Lists But Took No Action

The Dream

From our advertisers